MetLife Investment Management, LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 215 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$40,773
-53.9%
67,9780.0%0.00%
-100.0%
Q2 2023$88,371
-26.1%
67,9780.0%0.00%0.0%
Q1 2023$119,641
-30.8%
67,978
+23.4%
0.00%0.0%
Q4 2022$172,929
-47.2%
55,073
-17.6%
0.00%
-66.7%
Q3 2022$327,487
+18.4%
66,8340.0%0.00%
+50.0%
Q2 2022$276,693
-20.2%
66,834
+12.0%
0.00%0.0%
Q1 2022$346,671
+3.7%
59,668
+33.9%
0.00%
-33.3%
Q4 2021$334,283
-16.8%
44,5710.0%0.00%
-25.0%
Q3 2021$401,585
-24.7%
44,5710.0%0.00%
-20.0%
Q2 2021$533,515
-4.5%
44,5710.0%0.01%0.0%
Q1 2021$558,475
-32.4%
44,571
-15.8%
0.01%
-37.5%
Q4 2020$825,941
+65.1%
52,9280.0%0.01%
+60.0%
Q3 2020$500,170
+5.5%
52,9280.0%0.01%0.0%
Q2 2020$474,235
+40.7%
52,9280.0%0.01%0.0%
Q1 2020$337,151
-23.9%
52,9280.0%0.01%0.0%
Q4 2019$443,007
-7.5%
52,9280.0%0.01%0.0%
Q3 2019$478,998
-16.0%
52,9280.0%0.01%
-16.7%
Q2 2019$570,033
+26.7%
52,928
+12.2%
0.01%
+20.0%
Q1 2019$449,878
-16.9%
47,1570.0%0.01%
-28.6%
Q4 2018$541,362
-32.3%
47,1570.0%0.01%
-12.5%
Q3 2018$799,311
+19.3%
47,1570.0%0.01%0.0%
Q2 2018$670,000
-10.1%
47,157
+20.3%
0.01%
-11.1%
Q1 2018$745,000
+15.9%
39,1860.0%0.01%
+28.6%
Q4 2017$643,00039,1860.01%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
WASATCH ADVISORS LP 17,986,781$10,788,4710.07%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 254,257$12,7900.03%
Long Focus Capital Management, LLC 1,372,000$822,9260.03%
GSA CAPITAL PARTNERS LLP 559,731$3360.03%
Rokos Capital Management LLP 6,474,348$3,940,9360.03%
Golden State Equity Partners 166,265$99,7260.03%
State of Wyoming 92,360$55,3980.01%
ExodusPoint Capital Management, LP 1,890,425$1,1340.01%
ACADIAN ASSET MANAGEMENT LLC 2,927,769$1,7530.01%
Fort Sheridan Advisors LLC 53,831$32,2880.01%
View complete list of SANGAMO THERAPEUTICS INC shareholders